BioSpace News Archive

Advanced Dermatology and Cosmetic Surgery, one of the country’s leading dermatology practices, announces the acquisition of Esterson Dermatology located in Pikesville, Maryland.

Seno Medical’s Imagio® Breast Imaging System, a revolutionary new modality in breast imaging, has received supplemental premarket approval (PMA) from the Center for Devices and Radiological Health (CDRH) of the US Food & Drug Administration (FDA).

Data for CY6463, a first-in-class, CNS-penetrant, sGC stimulator, demonstrate safety and positive effects across biomarkers of disease in MELAS patients.

ResMed announced the promotion of Lucile Blaise to President of Sleep & Respiratory Care, effective July 1, 2022.

CardieX Limited (ASX: CDX), has together with its manufacturing partner Andon filed a 510(k) premarket submission with the U.S. Food and Drug Administration (FDA) for the CONNEQT Pulse (Pulse) – a world first dual blood pressure and arterial health monitor targeted at the home health, remote patient monitoring, and decentralized clinical trial markets.

iNtRON Biotechnology (“iNtRON”) announced today that SAL200, a endolysin-based novel antibacterial treatment for Staph superbugs including MRSA, has come back to the market and is now on-the table for an out-licensing deal.

Cargene Biopharma Inc. (“Cargene”, the “Company”), a biopharmaceutical company developing oligonucleotide therapeutics for liver and ophthalmic disorders, is excited to welcome Kathy He , a seasoned biopharmaceutical industry executive, to join the Company as Chief Executive Officer and a member of the board.

Recent Developments at the University of Iowa have Resulted in an Improved Formulation of JAN101.

Deep Blue Medical Advances, developer of the T-Line® Hernia Mesh, today announced the close of its Series A1 funding round.

Partnership will transform ASC cardiovascular care delivery and expand patient access.